Thomas P. Conrads

Pharmacologic inhibition of ATR and ATM offers clinically important distinctions to enhancing platinum or radiation response in ovarian, endometrial, and cervical cancer cells.

Proteomics of the human endometrial glandular epithelium and stroma from the proliferative and secretory phases of the menstrual cycle.

Identification and functional characterization of a novel bipartite nuclear localization sequence in ARID1A.

Race-specific molecular alterations correlate with differential outcomes for black and white endometrioid endometrial cancer patients.

Recent advances and opportunities in proteomic analyses of tumour heterogeneity.

Efficient identification of neoantigen-specific T-cell responses in advanced human ovarian cancer.

Jupiter microtubule-associated homolog 1 (JPT1): A predictive and pharmacodynamic biomarker of metformin response in endometrial cancers.

Racial disparities in uterine and ovarian carcinosarcoma: A population-based analysis of treatment and survival.

The impact of ultraviolet- and infrared-based laser microdissection technology on phosphoprotein detection in the laser microdissection-reverse phase protein array workflow.

Molecular Analysis of Clinically Defined Subsets of High-Grade Serous Ovarian Cancer.

Standardization and harmonization of distributed multi-center proteotype analysis supporting precision medicine studies.

Proteogenomic landscape of uterine leiomyomas from hereditary leiomyomatosis and renal cell cancer patients.

Extensive three-dimensional intratumor proteomic heterogeneity revealed by multiregion sampling in high-grade serous ovarian tumor specimens.

Peptide ancestry informative markers in uterine neoplasms from women of European, African, and Asian ancestry.

Whole-Genome Sequencing Identifies as a Putative Modifier of Cancer Risk in Mutation Carriers.